ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 53 filers reported holding ADMA BIOLOGICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,768,217 | +13.4% | 773,245 | +16.9% | 0.01% | +16.7% |
| Q2 2023 | $2,441,356 | -19.1% | 661,614 | -27.5% | 0.01% | -25.0% |
| Q1 2023 | $3,018,593 | +58.2% | 911,962 | +85.5% | 0.01% | +60.0% |
| Q4 2022 | $1,907,610 | +140.6% | 491,652 | +50.8% | 0.01% | +150.0% |
| Q3 2022 | $793,000 | +771.4% | 326,112 | +1328.7% | 0.00% | – |
| Q4 2019 | $91,000 | +4450.0% | 22,825 | +7286.7% | 0.00% | – |
| Q3 2018 | $2,000 | – | 309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |